Your browser doesn't support javascript.
loading
Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis.
Zenner, Dominik; Beer, Netta; Harris, Ross J; Lipman, Marc C; Stagg, Helen R; van der Werf, Marieke J.
Afiliación
  • Zenner D; From Institute for Global Health, University College London; Public Health England; and Royal Free London National Health Service Foundation Trust, London, United Kingdom, and European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Beer N; From Institute for Global Health, University College London; Public Health England; and Royal Free London National Health Service Foundation Trust, London, United Kingdom, and European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Harris RJ; From Institute for Global Health, University College London; Public Health England; and Royal Free London National Health Service Foundation Trust, London, United Kingdom, and European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Lipman MC; From Institute for Global Health, University College London; Public Health England; and Royal Free London National Health Service Foundation Trust, London, United Kingdom, and European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • Stagg HR; From Institute for Global Health, University College London; Public Health England; and Royal Free London National Health Service Foundation Trust, London, United Kingdom, and European Centre for Disease Prevention and Control, Stockholm, Sweden.
  • van der Werf MJ; From Institute for Global Health, University College London; Public Health England; and Royal Free London National Health Service Foundation Trust, London, United Kingdom, and European Centre for Disease Prevention and Control, Stockholm, Sweden.
Ann Intern Med ; 167(4): 248-255, 2017 Aug 15.
Article en En | MEDLINE | ID: mdl-28761946

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazinamida / Rifampin / Tuberculosis Latente / Isoniazida / Antituberculosos Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Systematic_reviews Límite: Adult / Child / Humans Idioma: En Revista: Ann Intern Med Año: 2017 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirazinamida / Rifampin / Tuberculosis Latente / Isoniazida / Antituberculosos Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Systematic_reviews Límite: Adult / Child / Humans Idioma: En Revista: Ann Intern Med Año: 2017 Tipo del documento: Article País de afiliación: Suecia